Showing 1,285 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

ViiV Healthcare announces US FDA approval for Rukobia (fostemsavir), a first-in-class treatment for HIV in adults with few treatment options available

Editor's pick
ViiV press release
3 July 2020
New & experimental HIV treatments

Experimental HIV drug seems effective at a twice-a-year dose, study finds

Editor's pick
STAT
2 July 2020
New & experimental HIV treatments

Existing drugs may limit damage caused by HIV

Editor's pick
EurekAlert
24 June 2020
Coronavirus

New trial will give 75 coronavirus patients experimental HIV and cancer drug this month after two critically ill people in New York treated with the medication recovered

Editor's pick
Daily Mail
6 May 2020
Injectable & long-acting HIV treatment

Health Canada okays GSK unit's monthly HIV injection

Editor's pick
Reuters
23 March 2020
New & experimental HIV treatments

Long-acting capsid inhibitor GS-6207 confirms safety and antiviral activity

News
12 March 2020
The search for an HIV prevention vaccine

HIV vaccine that generates broadly neutralising antibodies passes first safety and proof-of-concept study in humans

News
12 March 2020
Injectable & long-acting HIV treatment

Long-acting injectables might be administered every two months

News
11 March 2020
The search for a cure

Safety and PK of bNAb elipovimab (GS-9722) support two-weekly dosing

Editor's pick
i-Base
10 March 2020
New & experimental HIV treatments

Rockefeller grants commercial license for the development of broadly neutralizing antibodies

Editor's pick
Rockefeller University
27 February 2020
Injectable & long-acting HIV treatment

Unitaid invests in long-acting medicines to simplify treatment and prevention for HIV, TB, malaria and HCV

Editor's pick
Unitaid
7 February 2020
New & experimental HIV treatments

ViiV Healthcare submits regulatory application to the European Medicines Agency for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults with few treatment options available

Editor's pick
ViiV Healthcare press release
13 January 2020
Injectable & long-acting HIV treatment

No holiday gift for GSK: FDA sends long-acting HIV injectable back to work

Editor's pick
FiercePharma
24 December 2019
Injectable & long-acting HIV treatment

FDA Defers Approval of First Long-Acting HIV Therapy, Surprising Everyone

Editor's pick
HIV and ID Observations
23 December 2019
New & experimental HIV treatments

CytoDyn Signs Definitive Agreements with Vyera Pharmaceuticals to Commercialize Leronlimab in the U.S. for the Treatment of HIV

Editor's pick
CytoDyn press release
18 December 2019
New & experimental HIV treatments

Capsid inhibitor GS-6207: potential for 6 monthly dosing for MDR HIV

Editor's pick
i-Base
16 December 2019
New & experimental HIV treatments

ViiV Healthcare submits New Drug Application to the FDA for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults with few treatment options available

Editor's pick
5 December 2019
Injectable & long-acting HIV treatment

Effectiveness and frequency of dosing are the most important factors affecting acceptability of injectable HIV therapy, says US study

News
29 November 2019
Government, leadership & policy

The World Cannot End HIV Without Continued Innovation

Editor's pick
POZ
25 November 2019
New & experimental HIV treatments

ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational "bNAb" with potential for long-acting HIV treatment and prevention

Editor's pick
ViiV Healthcare press release
21 November 2019
New & experimental HIV treatments

Oral cabotegravir and rilpivirine still effective at 312 weeks

News
14 October 2019
New & experimental HIV treatments

Ibalizumab monoclonal antibody is effective in real-world use

News
7 October 2019
PrEP science

Evaluating Microarray Patches for Long-Acting PrEP and Contraceptives

Editor's pick
Contagion Live
3 October 2019
New & experimental HIV treatments

European Commission Approves Trogarzo

Editor's pick
Global Newswire
27 September 2019